Adamcapital Gestao De Recursos Ltda. Biogen Inc. Transaction History

Adamcapital Gestao De Recursos Ltda.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 30, 2019	SELL	$216.71 - $338.96 $26.1 Million - $40.8 Million	-120,320 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$278.5 - $352.75 $6.22 Million - $7.88 Million	22,350 Added 22.81%	120,320 $36.2 Million
Q3 2018 Oct 22, 2018	SELL	$293.51 - $383.83 $8.18 Million - $10.7 Million	-27,886 Reduced 22.16%	97,970 $34.6 Million
Q2 2018 Jul 19, 2018	SELL	$257.52 - $306.91 $14.2 Million - $17 Million	-55,267 Reduced 30.51%	125,856 $36.5 Million
Q1 2018 Apr 13, 2018	BUY	$260.13 - $367.91 $22.7 Million - $32.1 Million	87,280 Added 93.01%	181,123 $49.6 Million
Q4 2017 Feb 22, 2018	BUY	$307.64 - $344.58 $28.9 Million - $32.3 Million	93,843	93,843 $29.9 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Adamcapital Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

Stay updated on Adamcapital Gestao De Recursos Ltda. with notifications on news.